Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members in a competitive market, the Swiss Biotech Association works to secure favorable framework conditions and facilitate access to talents, novel technologies and financial resources. To strengthen and promote the Swiss biotech industry, the Swiss Biotech Association collaborates with numerous partners and life science clusters globally under the brand Swiss Biotech™.

Media Info

Our media releases, presentations for the media and useful links

Contact

Swiss Biotech Association
Stauffacherstrasse 16
8004 Zürich
T: +41 44 455 56 78
E-mail

2021

May 12, 2021

Weakening patent protection for COVID-19 vaccines does not help to accelerate vaccine production but endangers science-based innovation

The proposal to the WTO, to weaken the patent protection for COVID-19 vaccines, incorrectly portrays IP as the barrier to rapid access to vaccines. While this initiative does not address the crisis in an effective manner, it does send an extremely dangerous signal to innovators and investors alike. A robust and reliable IP protection is indispensable for science-based innovation. What sounds good at first glance is dangerous as it risks to significantly weaken our ability to foster and finance healthcare innovation.

April 20, 2021

Agility, leadership and innovation – New Swiss Biotech Report shows exceptional sector performance

Capital investments in Swiss biotech companies almost tripled from 2019 to 2020 reaching CHF 3.4B (USD 3.7B) – R&D investments increased by 10% to CHF 2.2B (USD 2.3B) – The number of employees in Swiss R&D biotech companies increased by 8% to 16,300 – High quality patent output helped maintain Switzerland’s top ranking in Global Innovation Index for the tenth consecutive year – From rapid diagnostic test and vaccine manufacturing to drug repurposing, Swiss biotech companies made significant contributions to address the impact of the COVID-19 pandemic

The Swiss Biotech Report “Aglity, leadership and innovation in the time of COVID-19” launched by the Swiss Biotech Association in conjunction with EY and eight other partner organizations provides analysis of funding, M&A activity and collaborations. The report also highlights projects and companies that were part of the Swiss response to the COVID-19 pandemic.

More on the Swiss Biotech Report

March 31, 2021

Swiss Biotech Association now at headquarters of the Basel Chamber of Commerce

The Swiss Biotech Association will open a representative office at the Basel Chamber of Commerce on April 1, 2021. This demonstrates its commitment to Basel as a life sciences location with its innovative companies. Together with the Basel Chamber of Commerce, they are committed to a strong, competitive life sciences industry in the Basel region and Switzerland.

February 26, 2021

Swiss Biotech Success Stories with new jury members

Since 2018, the Swiss Biotech Association has been honoring outstanding achievements with the Swiss Biotech Success Stories Awards. Innovative companies, entrepreneurs and scientists are recognized by the industry association for their significant successes and lasting contributions to the Swiss biotech industry. Stefanie Flückiger-Mangual, Seraina Gross and Daniela Marino have now joined the Swiss Biotech Success Stories jury.

More on the Swiss Biotech Success Stories

Media releases & presentations 2021

Media release: Agility, leadership and innovation – New Swiss Biotech Report shows exceptional sector performance

Download PDF Capital investments in Swiss biotech companies almost tripled from 2019…

Apr 20, 2021
Medienmitteilung: Agilität, Führung und Innovation – Neuer Swiss Biotech Report zeigt hervorragende Branchenleistung

Download PDF Ob in der Entwicklung von Schnelldiagnosetests, neuer Therapiemethoden…

Apr 20, 2021
Presentation for the media: Swiss Biotech Report 2021

The Swiss Biotech Report media presentation 2021 is only available in English Download PDF

Apr 20, 2021
Swiss Biotech Association now at headquarters of the Basel Chamber of Commerce

Download PDF The Swiss Biotech Association will open a representative office at the…

Mar 31, 2021
Swiss Biotech Association neu am Sitz der Handelskammer beider Basel

Download PDF Die Swiss Biotech Association eröffnet am 1. April 2021 eine Repräsentanz…

Mar 31, 2021
Swiss Biotech Success Stories with new jury members

Download PDF Since 2018, the Swiss Biotech Association has been honoring outstanding…

Feb 26, 2021

2020

September 21, 2020

Seven outstanding Swiss biotech achievements awarded

Each year, the Swiss Biotech Association awards companies or individuals with the Swiss Biotech Success Stories Awards in recognition of outstanding achievements. Actelion, Debiopharm, Helsinn, Venture Kick, >>Venture>>, Venturelab, and the noble prize-winner Professor Werner Arber receive the awards in 2020.

More on the Swiss Biotech Success Stories

April 21, 2020

Swiss Biotech Report 2020 highlights continued sector growth

Over CHF 1 billion raised for private and public companies – Gene therapy, AI and advanced biologics manufacturing emerging as additional strengths – Licensing deals and collaborations boost revenues – Swiss biotech ecosystem becomes even more diverse
 
With one of the most comprehensive life sciences ecosystems in the world, Swiss biotech continues to thrive. The 2020 edition of the Swiss Biotech Report by the Swiss Biotech Association in conjunction with EY and seven other partners, provides highlights and analysis of funding, M&A and collaborations, as well as a special focus on the exciting new artificial intelligence scene.
 
April 21, 2020

Laureates nominated for the Swiss Biotech Success Story Awards

Each year, the Swiss Biotech Association awards companies or individuals in recognition of outstanding achievements.

The award winners for 2020 are Actelion, Debiopharm, Helsinn, Venture Kick, >>Venture>>, Venturelab, and the noble prize-winner Professor Werner Arber.

Nominated this year for the Swiss Biotech Success Stories Awards in 2021 are Bachem, Basilea, Esbatech, Lonza, and Novimmune.

More on the Swiss Biotech Success Stories

Media releases & presentations 2020

Media release: Seven outstanding Swiss biotech achievements awarded

Download PDF Each year, the Swiss Biotech Association awards companies or individuals…

Sep 21, 2020
Sieben herausragende Schweizer Biotech-Leistungen ausgezeichnet

Download PDF Die Swiss Biotech Association zeichnet jedes Jahr Unternehmen oder…

Sep 21, 2020
Sept avancées remarquables en biotechnologie suisse récompensées

Download PDF Chaque année, la Swiss Biotech Association décerne aux entreprises ou aux…

Sep 21, 2020
Media release: Swiss Biotech Report 2020 highlights continued sector growth

Download PDF Over CHF 1 billion raised for private and public companies Gene therapy,…

Apr 21, 2020
Medienmitteilung: Swiss Biotech Report 2020 – 1,2 Milliarden für Schweizer Biotech-Unternehmen

Download PDF 2019 wurden 1,2 Milliarden Franken in private und öffentliche…

Apr 21, 2020
Communiqué aux médias: Le Swiss Biotech Report 2020 souligne la poursuite de la croissance dans le secteur

Download PDF Plus d’un milliard de CHF ont été levés pour les entreprises…

Apr 21, 2020
Presentation for the media: Swiss Biotech Report 2020

The Swiss Biotech Report media presentation 2020 is only available in English Download PDF

Apr 21, 2020